echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Fibli is a non-cloth of Japanese original research! Has been in Ali, JD.com platform for sale

    Fibli is a non-cloth of Japanese original research! Has been in Ali, JD.com platform for sale

    • Last Update: 2021-01-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, for the treatment of gout in Japan's original research drug non-clothta (commodity name: Fibuli ®) the entire layout of the domestic online pharmaceutical e-commerce platform including Ali, JD.com and major retail pharmacies, for 80 million Chinese gout patients to provide convenient online drug purchase channels, in order to further enhance gout patients in the domestic market drug access.
    The large population of domestic gout patients non-cloth he recommended for the guide first-line uric acid drugs in recent years, with the change of people's daily life and eating habits, the incidence of hyperureticemia in China increased year by year, and showed a clear trend of youth, known as high blood pressure, hyperlipidemia, high blood sugar after the "fourth high."
    and high uric acidemia were closely related. More than
    studies have shown that hypoureticemia is an abnormal metabolic syndrome caused by metabolic disorders, and that uric acid exceeds its saturation in blood or tissue fluids to form sodium uric acid crystals and deposit them locally in the joints, inducing local inflammatory reactions and tissue damage, i.e. gyro.
    gout symptoms, mainly manifested in the night sudden joint pain, acute onset, serious pain, edema, redness and inflammation of the joint area.
    In addition, gover can be associated with kidney lesions, serious joint damage, kidney function damage, often accompanied by hyperlipidemia, hypertension, diabetes, arteriosclerosis and coronary heart disease, such as a serious threat to health and life expectancy.
    "China's guidelines for the diagnosis and treatment of high uric acidemia and gout (2019)" pointed out that gout patients should actively take uric acid treatment, and recommended non-busta, ethyl alcohol and other first-line drugs.
    specific choices for anti-uric acid drugs, the guidelines show that non-bustams are superior to allopurinols in terms of efficacy and adverse reactions.
    As a new uric acid-lowering drug, non-bustam reduces blood uric acid by inhibiting the activity of both jaundice oxidase and jaundice reductase, so the efficacy is superior to those of allopurinol.
    In addition, non-cloth he belongs to a highly selective inhibitor, will not affect the body's other radon, steroid metabolism, compared to easy to trigger hypersensitivity reactions in the Han family of beanin is less adverse reactions, and can provide kidney protection other than uric acid, chronic renal insemination patients are very friendly, so renal insemination patients should be preferred for uric acid treatment non-buttta.
    best-selling nearly 80 countries and regions in the past 40 years effectively control gout of the new drug is known to be non-cloth for the Japanese Imperial Pharmaceutical Co., Ltd. original research drugs, english named Febuxostat, Chinese commodity name: ®.
    was chemically synthesized by japanese emperors in 1999, it was first listed in the United States in 2009, because of its good efficacy, small side effects and other advantages, in the field of treatment drugs are not many high uric acidemia and glycation, known as the world's effective control of gyro in the past 40 years of new drugs.
    is currently listed in nearly 80 countries and regions around the world.
    In order to give our gout patients more high-quality options in the use of drugs, in September 2018, non-buffs were approved by the China Drug Administration to import, officially entered the domestic market®; As a commodity name officially listed in China, as Japan's original research high-quality drugs, Fibri ® in raw materials, accessories, preparation technology and other aspects of generic drugs are very different, in terms of quality, efficacy is better than domestic non-clothing.
    In addition, the new version of the Guide recommends non-cloth his initial dose of 20 mg, and domestic non-cloth he is 40 mg specifications, patients can only take medication, there is an inaccurate dosage and drug contamination, tablet loss and other risks, the next day to take the effect of the drug and compliance.
    therefore, irregular treatment can not better play a role in preventing gyrchics.
    compared to this, there are 20 mg of non-cloth can start from the recommended low dose, small dose incremental medication, the prevention of gout is more scientific, patient compliance is better.
    the drug name "silly can not distinguish" patients can be difficult to distinguish between many domestic patients in the purchase of drugs may have doubts, in the multi-channel attention to the treatment of gout drugs, such as "non-busta", "non-busotan", "Japanese emperor gout", "Fukushi pain", "Fibuli" and the English "Uloric", "Adenuric", Japanese "フェブリク", what is the difference? In fact, "non-bustam", "non-Busotan" and the above-mentioned English and Japanese are "Febuxostat" translation, are the japanese Imperial Pharmaceutical Co., Ltd. original research and production of drugs, because the translation and national operating agents are different, different Regional Chinese translations vary from country to country, such as フェブリク, often referred to in Japan as "フェブリク", in Taiwan, China, as "Fukushi", and in Hong Kong, China, and the mainland as "Fibuli".
    drugs are chemically identical in nature and efficacy, and are the same gyrogen drugs produced for japanese emperors, but there are some differences in packaging.
    , patients don't have to worry about the ® quality of Fibli and imperial gout.
    Fibli® is japan's original research non-cloth he (i.e., emperor gout) gout patient gospel: Fibuli has officially landed in Ali Jingdong and major retail pharmacies in recent years, many gout patients out of the Japanese original research drug quality and efficacy recognition, long-term through various channels from Japan or Europe and the United States, Hong Kong and Taiwan on behalf of the purchase of imperial non-cloth, not only expensive, but also may buy counterfeit drugs.
    and this year due to the impact of the outbreak, the purchase cycle is uncertain, it is easy to appear the risk of drug cut-off, which requires daily regular medication for chronic patients with great inconvenience.
    In order to facilitate the purchase of domestic consumers, the original research emperor non-cloth his domestic version of Fibuli® has been listed in China, Fibuli® earlier this year landed in the domestic retail pharmacies, and recently landed in the major e-commerce platform, patients with prescriptions can be in retail pharmacies, or Ali, JD.com and other online easy to buy Japanese original drugs.
    it should be noted that patients need to take scientific and rational medication after purchasing the drug, preferably following the guidelines recommended for a small dose of 20 mg starting, slowly increase to avoid or reduce gout attacks.
    long-term treatment options for small dose maintenance and regulation, i.e. titration therapy, titration acid can stabilize the standard, and the dose is small and safer.
    And in addition to the protection of drug treatment, patients also need to follow the doctor's advice, in the diet structure to improve the corresponding, reduce the intake of sorghum food, but also to appropriately limit the total amount of protein intake and sugary beverage intake.
    References: 2016 China Ginge Clinic Guide. Chinese Journal of Internal Medicine - Chinese Medical Association Rheumatology Credit Union (citing date 2018-08-21) the relationship between dietary nutrition and high uric acidemia and gyrations. International Journal of Endocrine Metabolism (quote date2018-08-21)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.